Nancy Stagliano - Net Worth and Insider Trading
Nancy Stagliano Net Worth
The estimated net worth of Nancy Stagliano is at least $4 Million dollars as of 2025-05-12. Nancy Stagliano is the Director of Pandion Therapeutics Inc and owns about 74,067 shares of Pandion Therapeutics Inc (PAND) stock worth over $4 Million. Details can be seen in Nancy Stagliano's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nancy Stagliano has not made any transactions after 2020-07-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nancy Stagliano
Nancy Stagliano Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nancy Stagliano owns 1 companies in total, including Pandion Therapeutics Inc (PAND) .
Click here to see the complete history of Nancy Stagliano’s form 4 insider trades.
Insider Ownership Summary of Nancy Stagliano
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| PAND | Pandion Therapeutics Inc | 2020-07-21 | director |
Nancy Stagliano Latest Holdings Summary
Nancy Stagliano currently owns a total of 1 stock. Nancy Stagliano owns 74,067 shares of Pandion Therapeutics Inc (PAND) as of July 21, 2020, with a value of $4 Million.
Latest Holdings of Nancy Stagliano
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PAND | Pandion Therapeutics Inc | 2020-07-21 | 74,067 | 60.05 | 4,447,723 |
Holding Weightings of Nancy Stagliano
Nancy Stagliano Form 4 Trading Tracker
According to the SEC Form 4 filings, Nancy Stagliano has made a total of 1 transactions in Pandion Therapeutics Inc (PAND) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pandion Therapeutics Inc is the acquisition of 1,000 shares on July 21, 2020, which cost Nancy Stagliano around $18,000.
Insider Trading History of Nancy Stagliano
- 1
Nancy Stagliano Trading Performance
GuruFocus tracks the stock performance after each of Nancy Stagliano's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nancy Stagliano is -38.63%. GuruFocus also compares Nancy Stagliano's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nancy Stagliano within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nancy Stagliano's insider trading performs compared to the benchmark.
Performance of Nancy Stagliano
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.94 |  | | | | |
| Relative Return to S&P 500(%) | -3.35 | | | | | |
Nancy Stagliano Ownership Network
Ownership Network List of Nancy Stagliano
Ownership Network Relation of Nancy Stagliano
Nancy Stagliano Owned Company Details
What does Pandion Therapeutics Inc do?
Who are the key executives at Pandion Therapeutics Inc?
Nancy Stagliano is the director of Pandion Therapeutics Inc. Other key executives at Pandion Therapeutics Inc include director & 10 percent owner Daniel J. Becker , See Remarks Joanne L. Viney , and 10 percent owner Mva Investors, Llc .
Pandion Therapeutics Inc (PAND) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pandion Therapeutics Inc Insider Transactions
Nancy Stagliano Mailing Address
Above is the net worth, insider trading, and ownership report for Nancy Stagliano. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Nancy Stagliano's mailing address is: 2nd Floor Watertown Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
